company background image
VIRO logo

ViroGates CPSE:VIRO Stock Report

Last Price

DKK 12.10

Market Cap

DKK 99.8m

7D

-14.2%

1Y

72.9%

Updated

20 Dec, 2024

Data

Company Financials

VIRO Stock Overview

An in vitro diagnostics company, develops and markets prognostic products for the healthcare sector. More details

VIRO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

ViroGates A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for ViroGates
Historical stock prices
Current Share PriceDKK 12.10
52 Week HighDKK 31.00
52 Week LowDKK 5.20
Beta0.74
1 Month Change-24.38%
3 Month Change108.62%
1 Year Change72.86%
3 Year Change-92.07%
5 Year Change-64.41%
Change since IPO-85.85%

Recent News & Updates

Recent updates

ViroGates (CPH:VIRO) Is In A Good Position To Deliver On Growth Plans

Mar 06
ViroGates (CPH:VIRO) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That ViroGates (CPH:VIRO) Will Use Its Cash Wisely

Nov 21
We're Hopeful That ViroGates (CPH:VIRO) Will Use Its Cash Wisely

Will ViroGates (CPH:VIRO) Spend Its Cash Wisely?

Jun 14
Will ViroGates (CPH:VIRO) Spend Its Cash Wisely?

We're Not Very Worried About ViroGates' (CPH:VIRO) Cash Burn Rate

Sep 19
We're Not Very Worried About ViroGates' (CPH:VIRO) Cash Burn Rate

We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Apr 14
We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Dec 30
We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Shareholder Returns

VIRODK Medical EquipmentDK Market
7D-14.2%-3.8%-4.2%
1Y72.9%0.2%4.4%

Return vs Industry: VIRO exceeded the Danish Medical Equipment industry which returned 0.2% over the past year.

Return vs Market: VIRO exceeded the Danish Market which returned 4.4% over the past year.

Price Volatility

Is VIRO's price volatile compared to industry and market?
VIRO volatility
VIRO Average Weekly Movement26.2%
Medical Equipment Industry Average Movement3.8%
Market Average Movement4.2%
10% most volatile stocks in DK Market10.5%
10% least volatile stocks in DK Market2.6%

Stable Share Price: VIRO's share price has been volatile over the past 3 months compared to the Danish market.

Volatility Over Time: VIRO's weekly volatility has increased from 17% to 26% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200010Jakob Knudsenwww.virogates.com

ViroGates A/S, an in vitro diagnostics company, develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital emergency services to support the clinical decision on hospitalization or discharge of acute patients and to identify high-risk sepsis patients at an early stage, as well as used for the prognosis of lifestyle-related diseases, such as cardiovascular disease, type 2 diabetes, and cancer; and for the assessment of longevity and biological age in a non-hospital setting. The company’ products icludes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging that will allow clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression and outcome; and suPARnostic POC+, a point-of-care finger prick test that detects the level of suPAR in the blood.

ViroGates A/S Fundamentals Summary

How do ViroGates's earnings and revenue compare to its market cap?
VIRO fundamental statistics
Market capDKK 99.77m
Earnings (TTM)-DKK 13.23m
Revenue (TTM)DKK 7.25m

12.9x

P/S Ratio

-7.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIRO income statement (TTM)
RevenueDKK 7.25m
Cost of RevenueDKK 1.80m
Gross ProfitDKK 5.45m
Other ExpensesDKK 18.69m
Earnings-DKK 13.23m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 20, 2025

Earnings per share (EPS)-1.71
Gross Margin75.22%
Net Profit Margin-182.57%
Debt/Equity Ratio74.8%

How did VIRO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 17:53
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ViroGates A/S is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution